Kronos Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.62 | -$0.17 | -$0.42 |
| Q2 2024 | 1 | -$0.49 | -$0.13 | -$0.34 |
| Q3 2024 | 1 | -$0.41 | -$0.11 | -$0.28 |
| Q4 2024 | 2 | -$0.30 | -$0.22 | -$0.27 |
| Q1 2025 | 3 | -$0.32 | -$0.20 | -$0.26 |
| Q2 2025 | 2 | -$0.36 | -$0.10 | -$0.24 |
| Q3 2025 | 2 | -$0.36 | -$0.10 | -$0.25 |
| Q4 2025 | 2 | -$0.41 | -$0.11 | -$0.28 |
Kronos Bio, Inc. Earnings Date And Information
Kronos Bio, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.27 earnings per share for the quarter, topping analysts' consensus estimates of $-0.32 by $0.05. The company had revenue of 2.37 M for the quarter and had revenue of 6.29 M for the year. Kronos Bio, Inc. has generated $-2 earnings per share over the last year ($-1.95 diluted earnings per share) and currently has a price-to-earnings ratio of -0.62. Kronos Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based on prior year's report dates.
Kronos Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.23 | $2.10 M | $2.37 M | ||
| 08/08/2024 | Q2 2024 | -$0.32 | -$0.27 | 0.05 | $1.53 M | $2.69 M |
| 05/09/2024 | Q1 2024 | -$0.43 | -$0.50 | -0.07 | $2.52 M | |
| 03/21/2024 | Q4 2023 | -$0.51 | -$0.43 | 0.08 | $2.29 M | |
| 11/13/2023 | Q3 2023 | -$0.51 | -$0.54 | -0.03 | $1.40 M | $917,000 |
| 08/08/2023 | Q2 2023 | -$0.50 | -$0.52 | -0.02 | $1.67 M | $1.86 M |
| 05/10/2023 | Q1 2023 | -$0.43 | -$0.41 | 0.02 | $1.22 M | |
| 03/15/2023 | Q4 2022 | -$0.55 | -$0.52 | 0.03 | $0 | |
| 11/08/2022 | Q3 2022 | -$0.64 | -$0.55 | 0.09 | $0 | |
| 08/04/2022 | Q2 2022 | -$0.69 | -$0.58 | 0.11 | $0 | |
| 05/04/2022 | Q1 2022 | -$0.65 | -$0.65 | 0 | $0 | |
| 02/24/2022 | Q4 2021 | -$1.07 | -$1.13 | -0.06 | $0 | |
| 11/09/2021 | Q3 2021 | -$0.98 | -$0.61 | 0.37 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.51 | -$0.53 | -0.02 | $0 | |
| 05/11/2021 | Q1 2021 | -$0.43 | -$0.48 | -0.05 | $0 | |
| 03/23/2021 | Q4 2020 | -$1.10 | -$0.70 | 0.4 | $0 | |
| 11/18/2020 | Q3 2020 | -$1.47 | -$0.73 | 0.74 | $0 | |
| 06/29/2020 | Q2 2020 | -$0.17 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.25 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.19 | $0 |
Kronos Bio, Inc. Earnings: Frequently Asked Questions
-
When is Kronos Bio, Inc.'s earnings date?
Kronos Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates.
-
Did Kronos Bio, Inc. beat their earnings estimates last quarter?
In the previous quarter, Kronos Bio, Inc. (:KRON) reported $-0.27 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.32 by $0.05.
-
How can I listen to Kronos Bio, Inc.'s earnings conference call?
The conference call for Kronos Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Kronos Bio, Inc.'s conference call transcript?
The conference call transcript for Kronos Bio, Inc.'s latest earnings report can be read online.
-
How much revenue does Kronos Bio, Inc. generate each year?
Kronos Bio, Inc. (:KRON) has a recorded annual revenue of $6.29 M.
-
How much profit does Kronos Bio, Inc. generate each year?
Kronos Bio, Inc. (:KRON) has a recorded net income of $6.29 M. Kronos Bio, Inc. has generated $-1.95 earnings per share over the last four quarters.
-
What is Kronos Bio, Inc.'s price-to-earnings ratio?
Kronos Bio, Inc. (:KRON) has a price-to-earnings ratio of -0.62 and price/earnings-to-growth ratio is -0.03.
